As observed in Fig. 3 and the Supplementary DataSet S1, a significantly higher susceptibility for lysozyme + colistin was found for CF strains (no differences between early/late isolates) compared with those from bacteremia: a circa three-fold decrease in survival. This evidence concerns the gene LYZ and cystic fibrosis.